Laxmi Dental
- P/E
- 33.64
Key Fundamentals
MicrocapHealthcare Equipment & SuppliesHealthcarePrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 15.00%
- Debt to Equity
- 0.05
- EPS (TTM)
- ₹5.61
- Book Value
- ₹44.22
- Market Cap
- —
- P/E (TTM)
- 33.64
- P/B
- 4.27
- ROE
- 14.80%
- Dividend Yield
- 0.00%
- EBITDA
- ₹51.90 Cr
- 52W High
- ₹344.80
- 52W Low
- ₹155.88
- Day Range
- ₹178.16 – ₹193.50
- Volume
- 2,54,585
Peer Comparison
Healthcare › Medical Equipment › Medical Equipment & Supplies
| ₹1,381.80 | 123.38 | ₹15,607 Cr | 11.63 | 0.00% | 13.80% | 18.00% | ₹1,077 Cr | ₹125 Cr | |
| ₹1,586.80 | 51.04 | ₹15,325 Cr | 5.18 | 0.23% | 9.02% | 12.50% | ₹1,997 Cr | ₹313 Cr | |
| ₹25.23 | 66.39 | ₹1,611 Cr | 3.61 | 0.20% | 8.91% | 11.40% | ₹367 Cr | ₹24 Cr | |
| ₹311.10 | 148.85 | ₹1,603 Cr | 2.61 | 0.67% | 2.44% | 4.59% | ₹441 Cr | ₹11 Cr | |
| ₹527.15 | 24.98 | ₹1,243 Cr | 2.52 | 0.00% | 26.00% | 22.40% | ₹201 Cr | ₹34 Cr | |
| Laxmi Dental (this company) | ₹188.71 | 33.64 | ₹1,017 Cr | 4.27 | 0.00% | 14.80% | 15.00% | ₹287 Cr | ₹31 Cr |
| ₹608.10 | — | ₹868 Cr | 5.64 | 0.00% | 16.90% | 18.90% | — | — | |
| Median 7 companies | ₹527.15 | 58.72 | ₹1,603 Cr | 4.27 | 0.00% | 13.80% | 15.00% | ₹404 Cr | ₹33 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 40
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 34
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 61
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 89
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 26
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 22
- Poor
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 103% CAGR over last 5 years
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Working capital days have increased from 72.9 days to 182 days
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 7 | 6 | 6 |
| Oscillators | Bullish | 1 | 6 | 2 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bullish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 53.31
- Neutral
- MACD (12,26,9)
- −3.57
- Bullish
- SMA (50)
- 191.60
- Bearish
- SMA (200)
- 202.78
- Bearish
As of
Analyst Rating
1 of 1 analyst rates Buy, 0 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +24.75% |
|---|---|
| 3Y | +19.72% |
| 1Y | +16.32% |
| TTM | +16.67% |
Net profit
| 5Y | Turned to profit |
|---|---|
| 3Y | Turned to profit |
| 1Y | −9.38% |
| TTM | +34.78% |
Operating cash flow
| 5Y | Turned negative |
|---|---|
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | +11.48 pp |
|---|---|
| 3Y | +10.27 pp |
| 1Y | −2.16 pp |
| TTM | −0.64 pp |
Revenue by year
| Mar 2020 | ₹150 Cr |
|---|---|
| Mar 2021 | ₹92.00 Cr |
| Mar 2022 | ₹137 Cr |
| Mar 2023 | ₹162 Cr |
| Mar 2024 | ₹194 Cr |
| Mar 2025 | ₹239 Cr |
| Mar 2026 | ₹278 Cr |
Net profit by year
| Mar 2020 | −₹5.00 Cr |
|---|---|
| Mar 2021 | −₹5.00 Cr |
| Mar 2022 | −₹19.00 Cr |
| Mar 2023 | −₹4.00 Cr |
| Mar 2024 | ₹25.00 Cr |
| Mar 2025 | ₹32.00 Cr |
| Mar 2026 | ₹29.00 Cr |
Analyst Forecasts
Quarterly Results
₹ Cr| Particulars | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 48 | 55 | 60 | 57 | 62 | 61 | 66 | 72 | 66 | 74 | 75 |
| Expenses | 44 | 43 | 46 | 48 | 52 | 51 | 54 | 61 | 59 | 60 | 60 |
| Operating Profit | 4 | 12 | 14 | 9 | 10 | 10 | 12 | 11 | 7 | 14 | 14 |
| OPM % | 8% | 21% | 23% | 15% | 16% | 16% | 18% | 15% | 11% | 18% | 19% |
| Other Income | 0 | 0 | 6 | 1 | 1 | 2 | 2 | 2 | −4 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| PBT | −1 | 7 | 16 | 5 | 5 | 6 | 10 | 9 | −1 | 11 | 12 |
| Tax % | −140% | 16% | 11% | 23% | 23% | 41% | 24% | 20% | −175% | 4% | 21% |
| Net Profit | 2 | 8 | 17 | 6 | 5 | 4 | 8 | 9 | 2 | 10 | 10 |
| EPS (₹) | 74.05 | 244 | 6.04 | 2.12 | 0.93 | 0.78 | 1.53 | 1.55 | 0.36 | 1.83 | 1.87 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 150 | 92 | 137 | 162 | 194 | 239 | 278 | 287 |
| Expenses | 146 | 88 | 130 | 152 | 169 | 196 | 234 | 241 |
| Operating Profit | 3 | 4 | 7 | 9 | 24 | 43 | 44 | 46 |
| OPM % | 2.3% | 4.6% | 4.8% | 6% | 13% | 18% | 16% | 16% |
| Other Income | 2 | 0 | −10 | 2 | 0 | 10 | 3 | 3 |
| Interest | 3 | 3 | 4 | 4 | 6 | 6 | 1.37 | 1 |
| Depreciation | 7 | 6 | 8 | 11 | 12 | 15 | 16 | 17 |
| PBT | −4 | −4 | −16 | −5 | 7 | 31 | 29 | 31 |
| Tax % | 5% | 8% | 15% | 4% | −136% | 21% | 9% | — |
| Net Profit | −5 | −5 | −19 | −4 | 25 | 32 | 29 | 31 |
| EPS (₹) | Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank. | Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank. | Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank. | Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank. | Not comparable with later periods: it is stated on a share count about a hundred times or more different, so it is left blank. | 5.78 | 5.27 | 5.61 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 11 | 11 |
| Reserves | 37 | 33 | 9 | 6 | 31 | 198 | 232 |
| Borrowings | 37 | 39 | 50 | 50 | 61 | 20 | 13 |
| Other Liabilities | 31 | 34 | 43 | 40 | 46 | 60 | 40 |
| Total Liabilities | 106 | 106 | 103 | 97 | 139 | 288 | 297 |
| Fixed Assets | 39 | 42 | 40 | 40 | 46 | 51 | 63 |
| CWIP | 0 | 7 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 6 | 10 | 27 |
| Other Assets | 66 | 56 | 63 | 56 | 87 | 227 | 207 |
| Total Assets | 106 | 106 | 103 | 97 | 139 | 288 | 297 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 12 | 10 | −2 | 14 | 8 | 44 | −5 |
| Investing | −18 | −9 | 3 | −10 | −11 | −29 | −78 |
| Financing | 6 | 0 | −4 | −1 | −3 | 111 | −18 |
| Net Cash Flow | 0 | 0 | −3 | 3 | −5 | 125 | −101 |
| Free Cash Flow | −5 | 0 | 0 | 5 | −5 | 28 | −23 |
| CFO/OP | 357 | 226 | −30 | 157 | 38 | 109 | 4 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 64 | 64 | 54 | 46 | 47 | 56 | 60 |
| Inventory Days | 186 | 305 | 272 | 212 | — | 397 | 156 |
| Days Payable | 197 | 273 | 245 | 197 | — | 585 | 68 |
| Cash Conversion Cycle | 54 | 96 | 81 | 61 | 47 | −132 | 147 |
| Working Capital Days | 13 | 3 | −3 | −13 | 0 | 37 | 182 |
| ROCE % | — | 3% | −1% | 1% | 18% | 19% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Laxmi Dental insights
63 extracted metrics across FY20–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026Transcript PPT Recording
- Q2 FY26 concall · Nov 2025Transcript PPT
- Q1 FY26 concall · Aug 2025Transcript PPT
- General announcements 3 Nov 2026
- General announcements 28 Oct 2026
Frequently Asked Questions about Laxmi Dental
What does Laxmi Dental Ltd do?
Where is Laxmi Dental Ltd (LAXMIDENTL) listed?
Which sector does Laxmi Dental Ltd belong to?
What is the PE ratio of Laxmi Dental Ltd?
What is the 52-week high and low of Laxmi Dental Ltd?
What is the Return on Equity (ROE) of Laxmi Dental Ltd?
Company Information
Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/LAXMIDENTL.md for Laxmi Dental Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.